Collaborations & Alliances
-
Bio News | Collaborations & Alliances | Industry News | R&D
Crown Bio, SMOC Enter Strategic Alliance
To exclusively license and commercialize SMOC’s comprehensive collection of genetically engineered models08.15.18
-
Bio News | Collaborations & Alliances | Industry News
WDSrx Acquires Florida Pharmaceutical Products
WDSrx president Adam Runsdorf named Larry Lapila, a 35 year industry veteran, as president of the acquired company08.15.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Industry News | R&D
Altasciences Acquires SNBL's Preclinical Testing Business
Will add comprehensive preclinical safety testing services to Altasciences’ full service clinical and bioanalytical offerings08.15.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Trials & Filings
Stealth & Evotec Advance New Compound
Stealth expects to advance new pipeline candidate to clinical-stage studies by the end of 2019 using Evotec's INDiGO platform08.14.18
-
Collaborations & Alliances | Drug Development
Evotec AG, Haplogen Partner with Bayer in COPD
Aims to develop new antiviral compounds to reduce COPD exacerbation08.14.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Mustang Bio, St. Jude Partner for X-SCID
Most common form of severe combined immunodeficiency, affecting approximately one in 50,000 to 100,000 newborns worldwide08.13.18
-
Bio News | Breaking News | Collaborations & Alliances | Industry News | Packaging & Tracking | Serialization
SEA Vision Launches Smart PCA40
Compact all-in-one serialization & aggregation-ready manual workstation can be delivered, deployed & validated very quicklyVideos
-
Bio News | Collaborations & Alliances | Drug Development | Industry News
Allergan, Editas Announce Exercise of Development Options
Allergan has exercised its option to develop and commercialize EDIT-101 globally for the treatment of LCA1008.07.18
-
Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Jazz, University of Texas Enter Collaboration
The five year partnership has a goal of evaluating therapies for multiple hematologic malignancies08.07.18
-
Collaborations & Alliances | Industry News | Packaging & Tracking
ACG, Verinetics Partner for Track & Trace
Verinetics' software product, TraxSecur will be used for added security08.07.18
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News
Oxford BioMedica Enters Three-way Cystic Fibrosis Partnership
Teams up with UK Cystic Fibrosis Gene Therapy Consortium, Boehringer Ingelheim and Imperial Innovations08.06.18
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Delivery | Industry News | Injectables
Antares Enters Development Agreement With Pfizer
Will develop a combination drug device rescue pen08.06.18
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Regeneron, bluebird bio Form Cancer Collaboration
Aim to discover, develop and commercialize new cell therapies for cancer08.06.18
-
Bio News | Bioassay Development | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Abzena Signs Protein Engineering Agreement with NYU Langone Health
Tie-up centers around development of biopharmaceutical being developed for autoimmune disease.08.06.18
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Almac Discovery, Elasmogen and Innovate UK Collaborate to Develop Oncology Platform
£2M joint program receives grant to support research into next generation technology08.06.18
-
Collaborations & Alliances | Regulatory Affairs | Serialization
Abdi Ibrahim Selects rfxcel for FMD Compliance
Will support serialization software to ensure compliance with current & future international legislative requirements08.02.18
-
Collaborations & Alliances | Drug Development
Forge Therapeutics Achieves CARB-X Milestone
Is now eligible to receive as much as $4 million in additional support to advance novel IV/Oral LpxC antibiotic08.01.18
-
Bio News | Collaborations & Alliances | Industry News
Novartis and Albumedix Sign Agreement
To evaluate the development of several first-in-class therapeutics using Albumedix’s Veltis technology platform08.01.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Formulation Development | Industry News | R&D
Innovate UK Grants Phico £1.4M
To support the manufacturing development of its intravenous antibiotic, SASPject PT3.808.01.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Vasomune, AnGes Sign Global Agreement
For the development & commercialization of treatments for diseases tied to with blood vessel dysfunction & destabilization07.31.18
